Vivint Pharma's New $48M Injectables Facility in Hyderabad

India's Vivint Pharma, founded in 2022, intends to invest 400 crore rupees, or around $48 million, in the construction of an injectables production plant in Hyderabad. At the location, the corporation intends to hire up to 1,000 people.Situated on 5.5 acres in Hyderabad, Telangana's "Genome Valley," the facility will serve as Vivint's first production unit. According to a press release dated August 7, Vivint presently has an R&D facility close to the location.The anticipated completion date of the building as well as its intended square footage were not made public.

The Telangana chief minister, Sri Revanth Reddy, expressed his happiness with Vivint Pharma's investment in Genome Valley in the press statement. "With this investment, Telangana will continue to lead the way in promoting innovation in the life sciences industry."The initiative is a component of the business's effort to increase its market share in India.

After construction is finished, the plant will focus on creating and manufacturing injectable medications for the critical care and cancer industries in both the home and foreign markets.